BIO-key International, Inc.
BKYINASDAQIndustrials● Active
$4.13
+$0.00(+0.00%)
Market Cap$2745426
P/E Ratio—
52W High$19.7
52W Low$3.1
BIO-key International, Inc. (BKYI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BKYI · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 18, 2026EPS Actual
-$0.15
Est. -$0.60 · +75.0%
Revenue
$0.00B
Est. $0.00B · -2.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 18, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
BKYI reports quarterly as a NASDAQ-listed Security & Protection Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 18, 2026 | -$0.60 | -$0.15 | +75.0% | $0.00B | $0.00B | -2.5% |
| ▼ Q1 FY2026 | Mar 31, 2026 | -$0.70 | -$1.90 | -171.4% | $0.00B | $0.00B | -43.6% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -$0.12 | -$0.15 | -25.0% | $0.00B | $0.00B | -13.9% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.15 | -$0.20 | -33.3% | $0.00B | $0.00B | -0.2% |
| ▲ Q2 FY2025 | May 15, 2025 | -$0.24 | -$0.16 | +33.3% | $0.00B | $0.00B | +23.6% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$0.35 | -$0.53 | -51.4% | $0.00B | $0.00B | -36.4% |
| — Q4 FY2024 | Nov 14, 2024 | -$0.39 | -$0.39 | +0.0% | $0.00B | $0.00B | +0.0% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -$0.54 | -$1.00 | -85.2% | $0.00B | $0.00B | -42.9% |
Q2 FY2026
May 18, 2026Beat
EPS Actual
-$0.15
EPS Est.
-$0.60
EPS Surpr.
+75.0%
Revenue
$0.00B
Q1 FY2026
Mar 31, 2026Miss
EPS Actual
-$1.90
EPS Est.
-$0.70
EPS Surpr.
-171.4%
Revenue
$0.00B
Q4 FY2025
Nov 14, 2025Miss
EPS Actual
-$0.15
EPS Est.
-$0.12
EPS Surpr.
-25.0%
Revenue
$0.00B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.20
EPS Est.
-$0.15
EPS Surpr.
-33.3%
Revenue
$0.00B
Q2 FY2025
May 15, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.24
EPS Surpr.
+33.3%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$0.53
EPS Est.
-$0.35
EPS Surpr.
-51.4%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.39
EPS Est.
-$0.39
EPS Surpr.
+0.0%
Revenue
$0.00B
Q3 FY2024
Aug 14, 2024Miss
EPS Actual
-$1.00
EPS Est.
-$0.54
EPS Surpr.
-85.2%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.40 | $-0.40 | $-0.40 | 1 |
| Q3 FY2026 | $-0.70 | $-0.70 | $-0.70 | 1 |
| Q2 FY2026 | $-0.80 | $-0.80 | $-0.80 | 1 |
| Q1 FY2026 | $-0.60 | $-0.60 | $-0.60 | 1 |
| Q4 FY2025 | $-0.70 | $-0.70 | $-0.70 | 1 |
| Q3 FY2025 | $-1.20 | $-1.20 | $-1.20 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 18, 2026 | +75.0% | $4.25 | $4.27 | +0.47% |
| ▼ Q1 FY2026 | Mar 31, 2026 | -171.4% | $5.98 | $5.30 | -11.37% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -25.0% | $9.70 | $9.47 | -2.37% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -33.3% | $8.08 | $7.92 | -1.98% |
| ▲ Q2 FY2025 | May 15, 2025 | +33.3% | $8.29 | $8.49 | +2.41% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -51.4% | $11.20 | $8.56 | -23.57% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +0.0% | $10.30 | $10.20 | -0.97% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -85.2% | $14.20 | $14.00 | -1.41% |
Q2 FY2026+0.47%
Report Date
May 18, 2026
EPS Beat/Miss
+75.0%
Price Before
$4.25
Price After
$4.27
Q1 FY2026-11.37%
Report Date
Mar 31, 2026
EPS Beat/Miss
-171.4%
Price Before
$5.98
Price After
$5.30
Q4 FY2025-2.37%
Report Date
Nov 14, 2025
EPS Beat/Miss
-25.0%
Price Before
$9.70
Price After
$9.47
Q3 FY2025-1.98%
Report Date
Aug 13, 2025
EPS Beat/Miss
-33.3%
Price Before
$8.08
Price After
$7.92
Q2 FY2025+2.41%
Report Date
May 15, 2025
EPS Beat/Miss
+33.3%
Price Before
$8.29
Price After
$8.49
Q1 FY2025-23.57%
Report Date
Mar 27, 2025
EPS Beat/Miss
-51.4%
Price Before
$11.20
Price After
$8.56
Q4 FY2024-0.97%
Report Date
Nov 14, 2024
EPS Beat/Miss
+0.0%
Price Before
$10.30
Price After
$10.20
Q3 FY2024-1.41%
Report Date
Aug 14, 2024
EPS Beat/Miss
-85.2%
Price Before
$14.20
Price After
$14.00
Avg Beat Reaction+0.64%
Avg Miss Reaction-8.14%
Beat Rate3 / 8 quarters
Largest Move-23.57% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BKYI ends December
BIO-key International, Inc. (BKYI) most recently reported earnings on May 18, 2026 for Q2 FY2026, posting EPS of $-0.15 — beating the analyst consensus of $-0.60 by +75.0%. The next BKYI earnings date is expected around September 1, 2026.
Each quarter, investors track BKYI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BKYI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BKYI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BKYI earnings · 5 questionsBIO-key International, Inc.'s next earnings report is expected around September 1, 2026. BKYI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BKYI historically reports after market close (AMC).
BKYI earnings datewhen is BKYI earningsBKYI next earnings datewhen does BKYI report earningsBKYI earnings calendar
▸ Source: FMP · BIO-key International, Inc. SEC filings · US GAAP · BIO-key International, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026